Imaging correlates of pathology in corticobasal syndrome

Background: Corticobasal syndrome (CBS) can be associated with different underlying pathologies that are difficult to predict based on clinical presentation. The aim of this study was to determine whether patterns of atrophy on imaging could be useful to help predict underlying pathology in CBS. Methods: This was a case-control study of 24 patients with CBS who had undergone MRI during life and came to autopsy. Pathologic diagnoses included frontotemporal lobar degeneration (FTLD) with TDP-43 immunoreactivity in 5 (CBS-TDP), Alzheimer disease (AD) in 6 (CBS-AD), corticobasal degeneration in 7 (CBS-CBD), and progressive supranuclear palsy in 6 (CBS-PSP). Voxel-based morphometry and atlas-based parcellation were used to assess atrophy across the CBS groups and compared to 24 age- and gender-matched controls. Results: All CBS pathologic groups showed gray matter loss in premotor cortices, supplemental motor area, and insula on imaging. However, CBS-TDP and CBS-AD showed more widespread patterns of loss, with frontotemporal loss observed in CBS-TDP and temporoparietal loss observed in CBS-AD. CBS-TDP showed significantly greater loss in prefrontal cortex than the other groups, whereas CBS-AD showed significantly greater loss in parietal lobe than the other groups. The focus of loss was similar in CBS-CBD and CBS-PSP, although more severe in CBS-CBD. Conclusions: Imaging patterns of atrophy in CBS vary according to pathologic diagnosis. Widespread atrophy points toward a pathologic diagnosis of FTLD-TDP or AD, with frontotemporal loss suggesting FTLD-TDP and temporoparietal loss suggesting AD. On the contrary, more focal atrophy predominantly involving the premotor and supplemental motor area suggests CBD or PSP pathology.

[1]  C. Jack,et al.  Voxel-based morphometry in autopsy proven PSP and CBD , 2008, Neurobiology of Aging.

[2]  Joseph James Duffy,et al.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia , 2005, Neurocase.

[3]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[4]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[5]  K. Marder,et al.  Cortical basal ganglionic degeneration. , 2001, Science of aging knowledge environment : SAGE KE.

[6]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[7]  R. Jung Neuropsychological Assessment, 4th ed. , 2005 .

[8]  B. Boeve,et al.  Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome , 2005, Movement disorders : official journal of the Movement Disorder Society.

[9]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[10]  J. Hardy,et al.  Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. , 2006, Brain : a journal of neurology.

[11]  R. Petersen,et al.  Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations , 2007, Journal of neuropathology and experimental neurology.

[12]  C. Jack,et al.  Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. , 2004, Archives of neurology.

[13]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[14]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[15]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[16]  J. Grafman,et al.  Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. , 2009, Archives of neurology.

[17]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[18]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[19]  D. Dickson Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration , 1999, Journal of Neurology.

[20]  Clifford R Jack,et al.  Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. , 2007, Archives of neurology.

[21]  C R Jack,et al.  Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN , 2009, Neurology.

[22]  Nick C Fox,et al.  Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. , 2005, Archives of neurology.

[23]  Jennifer L. Whitwell,et al.  MRI Correlates of Protein Deposition and Disease Severity in Postmortem Frontotemporal Lobar Degeneration , 2009, Neurodegenerative Diseases.

[24]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[25]  John Q. Trojanowski,et al.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update , 2009, Acta Neuropathologica.

[26]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[27]  R. Petersen,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[28]  J. Trojanowski,et al.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations , 2008, Acta Neuropathologica.

[29]  G. Binetti,et al.  Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide , 2009, Neurobiology of Disease.

[30]  William T. Hu,et al.  Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[31]  C. Jack,et al.  Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration , 2006, Neurology.

[32]  Maria Luisa Gorno-Tempini,et al.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. , 2006, Archives of neurology.

[33]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[34]  P. Lantos,et al.  Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.

[35]  C. Jack,et al.  Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.

[36]  J. Hodges,et al.  Is the pathology of corticobasal syndrome predictable in life? , 2009, Movement disorders : official journal of the Movement Disorder Society.

[37]  Julie S. Snowden,et al.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.

[38]  Irene Litvan,et al.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.

[39]  C. Jack,et al.  Symmetric corticobasal degeneration (S-CBD). , 2010, Parkinsonism & related disorders.

[40]  J. Grafman,et al.  Alzheimer's disease presenting as corticobasal syndrome , 2006, Movement disorders : official journal of the Movement Disorder Society.

[41]  C. Jack,et al.  Prominent phenotypic variability associated with mutations in Progranulin , 2009, Neurobiology of Aging.